Beyond GLP-1s: Inside Obesity’s $80 Billion Second Wave
The first wave of obesity innovation proved a simple point: meaningful weight loss can be delivered at scale if patients can start therapy, stay on it, and afford it. GLP-1s turned obesity into one of ...
